BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
2.000
+0.005 (0.25%)
Jul 10, 2025, 4:00 PM - Market closed
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $12.11 million as of July 10, 2025. Its market cap has decreased by -72.88% in one year.
Market Cap
12.11M
Enterprise Value
86.98M
1-Year Change
-72.88%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $12.11M, a decrease of -92.98%. That is a compound annual growth rate of -30.35%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.50B |
| Johnson & Johnson | 374.02B |
| AbbVie | 334.70B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 277.49B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 232.25B |
| AstraZeneca | 216.19B |